Pilot trials in thrombosis: Purpose and pitfalls.

Area of Science:

• Clinical Trials Methodology
• Health Services Research

Background:

• Randomized controlled trials (RCTs) are vital for clinical practice but are resource-intensive and often fail.
• Pilot studies are essential for optimizing RCT design and feasibility, preventing resource waste.
• Pilot trials are often misunderstood as small-scale efficacy studies rather than feasibility assessments.

Purpose of the Study:

• To emphasize the value of well-conducted pilot studies in improving the success of full-scale clinical trials.
• To highlight the importance of feasibility assessment and design refinement in pilot trials.
• To illustrate effective pilot trial design using the TRIM-Line study as an example.

Main Methods:

• Adherence to the "CONSORT 2010 statement: extension to randomized pilot and feasibility trials" for high-quality reporting.
• Focus on assessing feasibility and refining trial design, not preliminary efficacy.
• Utilizing a specific pilot trial (TRIM-Line, NCT03506815) as a case study.

Main Results:

• Well-designed pilot trials enhance the likelihood of completing impactful, practice-changing full-scale trials.
• Pilot studies provide opportunities for investigator training and capacity building.
• The TRIM-Line pilot trial demonstrates a model for designing feasibility studies in thrombosis research.

Conclusions:

• Pilot trials are a valuable investment for improving clinical trial success rates.
• Adherence to reporting guidelines like CONSORT ensures the quality and utility of pilot studies.
• Effective pilot studies are foundational for advancing evidence-based clinical practice.